Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Show other versions (1)

Zuclopenthixol is usually used in parental form to manage acute agitation and psychosis.[1] It has high affinity for dopamine D1 and D2 receptors. There are very few reports of Neuroleptic Malignant Syndrome (NMS) with use of zuclopenthixol monotherapy. In this case report, we present a 35 year old...

Full description

Bibliographic Details
Main Authors: Anish Shouan, Ankit Kumar Sinha, Sandeep Grover
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Industrial Psychiatry Journal
Subjects:
neuroleptic malignant syndrome
side effects
zuclopenthixol
Online Access:http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2020;volume=29;issue=2;spage=349;epage=351;aulast=

Internet

http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2020;volume=29;issue=2;spage=349;epage=351;aulast=

Similar Items